FDA Adds New Testosterone Warnings
The FDA announced that it has approved class-wide labeling changes for all prescription testosterone products. The agency added a new warning and updated the “Abuse and Dependence” section to include new safety data from the published literature and case reports regarding risks associated with abuse and dependence of testosterone and other anabolic androgenic steroids (AAS)....

http://www.renalandurologynews.com/hypogonadism/fda-adds-new-testosterone-warnings/article/568358/
Like
Comment
Share